This is a post-mortem of the Remdesiver Clinical Trial. We pay our professionals good money to get a decent trial and they can't even get that right. Heads ought to roll.
Read Our Latest News
Do you like this post?
“Remdesivir for COVID-19” Study accidentally proved effectiveness of Hydroxychloroquine
Sign up for our email newsletter
Subscribe to receive the latest and most important updates for you
Be the first to comment